Your browser doesn't support javascript.
loading
Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.
Jermendy, György; Erdesz, Diana; Nagy, Laszlo; Yin, Don; Phatak, Hemant; Karve, Sudeep; Engel, Samuel; Balkrishnan, Rajesh.
Afiliação
  • Jermendy G; The Ohio State University, Columbus, OH 43210, USA. not@valid.com
Health Qual Life Outcomes ; 6: 88, 2008 Oct 31.
Article em En | MEDLINE | ID: mdl-18976457
AIM: The objective of this observational study was to assess the status of glycemic control and associated patient-reported outcomes in ambulatory Hungarian patients with type 2 diabetes mellitus (T2DM) who were prescribed either a sulfonylurea (SU) or a thiazolidinedione (TZD) in addition to the prior metformin (MF) monotherapy. METHODS: Type 2 diabetics aged > or = 30 years and who had added an SU or TZD to previous MF monotherapy at least 1 year prior to the visit date were identified during January 2006 to March 2007. Information on HbA1c (A1C), medication use and co-morbid conditions was extracted from the medical record up to 6 months prior to the addition of SU or TZD to MF (baseline), and a minimum of one year after the initiation of either SU or TZD. Glycemic control (A1C < 6.5%) was assessed using the last available A1C value in the medical record. Self-reported hypoglycemia, health-related quality of life (HRQoL) and treatment satisfaction were also assessed. RESULTS: A total of 414 patients (82% SU+MF and 18% TZD+MF) with a mean age of 60.5 years (SD = 9.4 years) participated in the study. About 27% of patients reported hypoglycemic episodes, with about one-third reporting episodes that resulted into interruption of activities or required medical/non-medical assistance. Three quarters of patients were not at glycemic goal and BMI was the only factor significantly associated with failure to have an A1C level < 6.5%. Patients' HRQoL was significantly associated with self-reported hypoglycemic episodes (p = 0.017), and duration of diabetes (p = 0.045). CONCLUSION: Nearly 75% of patients were not at A1C goal of < 6.5% despite using two oral anti-hyperglycemic medications. Approximately 9% of patients reporting hypoglycemia required some kind of medical/non-medical assistance. Greater BMI at baseline was associated with an A1C level > or = 6.5%. Finally, self- reports of hypoglycemia and duration of diabetes were associated with low HRQoL.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Sulfonilureia / Resultado do Tratamento / Satisfação do Paciente / Tiazolidinedionas / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Metformina Idioma: En Ano de publicação: 2008 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Sulfonilureia / Resultado do Tratamento / Satisfação do Paciente / Tiazolidinedionas / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Metformina Idioma: En Ano de publicação: 2008 Tipo de documento: Article